Polynucleotides for hair regrowth in androgenetic alopecia

Rejuran0 个研究点目标入组 30 人开始时间: 2024年5月25日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1.AGA Hamilton-Norwood Stages III to V (including Type III vertex) were enrolled. Subjects must maintain the normal hair length, color and style during the study.
•2.Female pattern hair loss Ludwig type I-II

•1.Patients who are not interested or deny about this study.
•2. Patient who is undertaking treatment for disease before this study periods:
•2.1 Treatment with topical medication within 6 months
•2.2 Treatment with systemic medication (Finasteride within 12 months,Minoxidil within 12 months, Dutasteride within 18 months)
•2.3 Using shampoo for hair growth stimulation (non- medicated) treatment or taking hair supplements within 3 months.
•2.4Treatment with oral supplement within 12 months
•2.5 Using shampoo for hair growth stimulation (non- medicated) treatment or taking hair supplements within 3 months
•2.6 Any other treatment for hair growth within 1 month.
•3.Patient with alopecia other than androgenetic alopecia
•4. Patient with other systemic disease like malnutrition, autoimmune disease, symptomatically immunocompromised disease like HIV, syphilis and cancer.
•5.Patient with lack of cooperation as well as psychological disorder.
•6. Patient with history of hair transplantation or restoration surgery.
•7.Patient who is unreliable or poor compliance

发起方

Rejuran